메뉴 건너뛰기




Volumn 46, Issue 3, 2000, Pages 173-179

Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma

Author keywords

Angiogenesis; Kaposi's sarcoma; Mass spectrometry; Metabolism; Pharmacokinetics; TNP 470

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE;

EID: 0033797806     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000149     Document Type: Article
Times cited : (22)

References (26)
  • 9
    • 0028176358 scopus 로고
    • A fumagillin derivative angiogenesis inhibitor, AGM 1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells
    • (1994) Cancer Res , vol.54 , pp. 3407
    • Abe, J.1    Zhou, W.2    Noriko, T.3    Junichi, T.4    Kiyoshi, K.5    Mamoru, K.6    Yoh, T.7
  • 15
    • 0028862259 scopus 로고
    • Determination of O-(chloroacetylcarbamoyl) fumagillol (TNP-470; AGM 1470) and two of its metabolites in plasma by high performance liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization
    • (1995) J Mass Spectrom , vol.30 , pp. 1707
    • Moore, J.D.1    Sommadossi, J.P.2
  • 21
    • 0027219286 scopus 로고
    • Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome associated Kaposi's sarcoma tissue and derived cells
    • (1993) Cancer , vol.77 , pp. 2253
    • Li, J.J.1    Huang, Y.Q.2    Moscatelli, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.